Burroughs Wellcome Co. / Hoffmann-La Roche’s Kuntzman / Merck and Co. Inc. / Hoffmann-La Roche Inc. / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
cor rect site / treatment of advanced cases of ovarian cancer / chemical compounds / healthcare / pharmaceutical / chemical effect / high-tech approach / chemical structures / chemical by-products / consumer products / pharmaceutical research / treatment of AIDS / manufacturing / breakdown products / chemical / chemical structure / chemicals / cholesterol chain / /
MedicalCondition
ovarian cancer / birth defects / cancer / disease / molecular dysfunction / heart attack / diseases / specific disease / AIDS / /
MedicalTreatment
antibiotics / chemotherapy / /
Organization
Congressional Office / Pharmaceutical Research and Manufacturers of America / FDA / /
Person
Ronald Kuntzman / Eve Slater / Richard Salvador / Clement Stone / Rhoda Gruen / /
Position
executive vice president for worldwide regulatory affairs / vice president for research and development / pharmacist / researcher / senior vice president / president of international research and development / vice president and international director of preclinical development / stubborn scientist / special assistant / /
The Beginnings: Laboratory and Animal Studies T